| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,330 | 25,878 | 25,707 | 25,716 | | Cost of Revenue | 5,131 | 5,643 | 5,732 | 5,748 | | | Gross Profit |
-
| 20,235 | 19,975 | 19,968 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,118 | 13,809 | 12,299 | 12,227 | | Non Recurring |
-
| (245) | 245 |
-
| | Others | 7,856 | 3,096 | 3,210 | 20,870 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 3,575 | 4,221 | (13,129) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 225 | 3,575 | 4,221 | (13,129) | | Interest Expense | 2,431 | 2,428 | 2,432 | 2,503 | | Income Before Tax | (2,206) | 1,147 | 1,789 | (15,632) | | Income Tax Expense | (453) | 326 | 654 | (5,679) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,753) | 821 | 1,135 | (9,953) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,753) | 821 | 1,135 | (9,953) | | Preferred Stock And Other Adjustments |
-
| (554) | (553) |
-
| | | Net Income Applicable To Common Shares | ($2,306) | $267 | $582 | ($9,953) |
|
0.49% Nasdaq 
Income Statement
